We are live on ! Find out more
Marshall Wace

Marshall Wace Portfolio holdings

AUM $127B Turnover 40.17%
1-Year Est. Return 46.06%
 

Marshall Wace is a British firm that runs long/short hedge funds. Its strategies combine computer-driven and traditional company analysis, applied worldwide and mostly to long/short equity. Paul Marshall, formerly head of European equities at Mercury Asset Management, and Ian Wace, formerly head of equities trading at Deutsche Bank, founded it in 1997. In 2002 it launched TOPS, a system that gathers investment ideas from equity professionals and uses algorithms to turn them into stock portfolios. In 2015 Marshall Wace formed a long-term partnership with KKR, a private equity and credit investor that took an ownership interest in the firm.

This Fund
S&P 500
This Quarter Est. Return
+7.42%
1 Year Est. Return
+46.06%
3 Year Est. Return
+142.12%
5 Year Est. Return
+190.33%
10 Year Est. Return
+787.47%
AUM
$14.1B
AUM Growth
+$2.17B
Cap. Flow
+$1.72B
Cap. Flow %
12.25%
Top 10 Hldgs %
18.97%
Holding
1,309
New
346
Increased
287
Reduced
265
Closed
392
Avg Time Held Equity + Options
0.6 years
Top 10 Avg Time Held Equity + Options
0.7 years
Top 20 Avg Time Held Equity + Options
0.6 years
Avg Time Held Equity only
0.6 years
Top 10 Avg Time Held Equity only
0.7 years
Top 20 Avg Time Held Equity only
0.6 years

Top Buys

Rank Stock Value
1
ZTS icon
Zoetis
ZTS
+$177M
2
LOW icon
Lowe's Companies
LOW
+$108M
3
STJ
St Jude Medical
STJ
+$95.4M
4
NWL icon
Newell Brands
NWL
+$88.6M
5
STZ icon
Constellation Brands
STZ
+$87.2M

Top Sells

Rank Stock Value
1
EMC icon
EMC CORPORATION
EMC
+$136M
2
UNH icon
UnitedHealth
UNH
+$99.3M
3
PYPL icon
PayPal
PYPL
+$85.4M
4
SBUX icon
Starbucks
SBUX
+$78.1M
5
CI icon
Cigna
CI
+$64.7M

Sector Composition

Rank Sector Weight
1 Healthcare 21.87%
2 Consumer Discretionary 12.7%
3 Communication Services 12.19%
4 Technology 10.38%
5 Industrials 9.57%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
ZTS icon
1
Zoetis
ZTS
$34.4B
$658M 4.68%
12,647,653
+3,487,675
+38% +$177M
2013 Q2
13 quarters
TMUS icon
2
T-Mobile US
TMUS
$170B
$407M 2.9%
8,719,354
+966,375
+12% +$44.4M
2013 Q2
13 quarters
GOOGL icon
3
Alphabet (Google) Class A
GOOGL
$3.43T
$279M 1.98%
6,941,080
+1,337,760
+24% +$52.3M
2015 Q3
4 quarters
EEM icon
4
iShares MSCI Emerging Markets ETF
EEM
$28.3B
$240M 1.7%
6,396,965
+1,347,345
+27% +$49.3M
2016 Q1
2 quarters
CHTR icon
5
Charter Communications
CHTR
$13.2B
$202M 1.44%
749,277
-213,884
-22% -$54M
2015 Q1
6 quarters
META icon
6
Meta Platforms (Facebook)
META
$1.58T
$186M 1.32%
1,449,554
+385,685
+36% +$47.9M
2014 Q1
10 quarters
AAP icon
7
Advance Auto Parts
AAP
$2.89B
$176M 1.25%
1,178,006
+386,880
+49% +$61.8M
2013 Q2
13 quarters
SHPG
8
DELISTED
Shire pic
SHPG
$174M 1.24%
898,338
-157,535
-15% -$30.7M
2015 Q4
3 quarters
SPGI icon
9
S&P Global
SPGI
$138B
$174M 1.23%
1,372,028
-43,722
-3% -$5.25M
2016 Q2
1 quarter
STZ icon
10
Constellation Brands
STZ
$23.8B
$172M 1.22%
1,034,844
+528,844
+105% +$87.2M
2015 Q3
4 quarters
EL icon
11
Estee Lauder
EL
$37.9B
$172M 1.22%
1,939,385
+702,593
+57% +$64.1M
2014 Q1
10 quarters
CMCSA icon
12
Comcast
CMCSA
$84.7B
$148M 1.05%
4,467,942
+1,715,012
+62% +$57.1M
2013 Q2
13 quarters
MCO icon
13
Moody's
MCO
$87.2B
$140M 1%
1,295,602
+86,106
+7% +$9.05M
2014 Q4
7 quarters
LOW icon
14
Lowe's Companies
LOW
$122B
$137M 0.97%
1,891,005
+1,385,672
+274% +$108M
2014 Q1
10 quarters
BSX icon
15
Boston Scientific
BSX
$64.2B
$135M 0.96%
5,692,264
+2,433,372
+75% +$58M
2016 Q1
2 quarters
NWL icon
16
Newell Brands
NWL
$2.54B
$130M 0.93%
2,475,528
+1,713,771
+225% +$88.6M
2015 Q4
3 quarters
LYB icon
17
LyondellBasell Industries
LYB
$21.6B
$129M 0.92%
1,599,689
-98,360
-6% -$7.6M
2013 Q2
13 quarters
AZO icon
18
AutoZone
AZO
$52.4B
$124M 0.88%
161,675
+85,520
+112% +$66.6M
2013 Q2
13 quarters
SHW icon
19
Sherwin-Williams
SHW
$85.1B
$111M 0.79%
1,204,233
-399,336
-25% -$38.7M
2013 Q2
13 quarters
ORLY icon
20
O'Reilly Automotive
ORLY
$73B
$109M 0.78%
5,850,825
-385,050
-6% -$7.22M
2013 Q2
13 quarters
UHS icon
21
Universal Health Services
UHS
$10.7B
$105M 0.75%
853,697
-163,795
-16% -$20.7M
2015 Q2
5 quarters
AMG icon
22
Affiliated Managers Group
AMG
$9.6B
$103M 0.73%
709,541
+106,850
+18% +$15.3M
2015 Q4
3 quarters
TAP icon
23
Molson Coors Class B
TAP
$8.06B
$103M 0.73%
933,834
+401,386
+75% +$40.8M
2014 Q3
8 quarters
HPE icon
24
Hewlett Packard
HPE
$67.9B
$102M 0.72%
7,679,440
-380,350
-5% -$4.7M
2015 Q4
3 quarters
DPZ icon
25
Domino's
DPZ
$10.6B
$101M 0.72%
666,576
+1,645
+0.2% +$240K
2015 Q1
6 quarters

Similar funds

Marshall Wace's Q3 2016 Portfolio in Review

As of Q3 2016, Marshall Wace held 1,309 positions worth $14.1B, up 18% from $11.9B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Marshall Wace deployed $1.72B of net new capital in Q3 2016, opening 346 new positions and adding to 287 existing holdings. Its largest new stake was St Jude Medical: 1,181,595 shares worth $94.2M.

By sector, the portfolio is most concentrated in Healthcare at 22% of assets, up from 20% a quarter earlier, followed by Consumer Discretionary and Communication Services.

On the sell side, the largest reduction was UnitedHealth, an estimated $99.3M trimmed.

  • Marshall Wace's largest Q3 2016 buy was St Jude Medical: 1,181,595 shares worth $94.2M.
  • Marshall Wace added most to Zoetis in Q3 2016, an estimated $177M increase.
  • Marshall Wace's biggest Q3 2016 reduction was UnitedHealth, cutting an estimated $99.3M.
  • Marshall Wace fully exited EMC CORPORATION in Q3 2016, selling an estimated $136M.
  • Marshall Wace's ten largest holdings make up 19% of its $14.1B portfolio in Q3 2016.
  • Marshall Wace opened 346 new positions and closed 392 in Q3 2016.
  • Marshall Wace's portfolio value rose 18% quarter-over-quarter to $14.1B.

Based on Marshall Wace's 13F filing for Q3 2016, filed 10 Nov 2016.